CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)

Clinical trial NCT03631576 · UNKNOWN

Trial details

NCT number: NCT03631576
Sponsor: Fujian Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory AML

Start date: 2018-08-10
Primary completion: 2021-08-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.